BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8465655)

  • 1. Silver-binding argyrophilic nucleolar organizer regions (AgNOR) in gall-bladder cancer: correlations with malignant grading and prognosis.
    Suzuki T; Takano Y; Kida Y; Okudaira M
    Acta Pathol Jpn; 1993; 43(1-2):36-43. PubMed ID: 8465655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer.
    Nakayama K; Abe R
    J Surg Oncol; 1995 Nov; 60(3):160-7. PubMed ID: 7475065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital image analysis of silver-stained nucleolar organizer region--associated proteins in endometrial cytologic samples.
    Mahovlić V; Audy-Jurković S; Ovanin-Rakić A; Bilusić M; Veldić M; Babić D; Bozikov J; Danilović Z
    Anal Quant Cytol Histol; 1999 Feb; 21(1):47-53. PubMed ID: 10068775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.
    Kida Y; Takano Y; Okudaira M
    J Cancer Res Clin Oncol; 1992; 119(1):49-54. PubMed ID: 1400566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
    Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
    Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized AgNOR analysis as a prognostic parameter in endometrial carcinoma, endometrioid type.
    Giuffrè G; Fulcheri E; Gualco M; Fedele F; Tuccari G
    Anal Quant Cytol Histol; 2001 Feb; 23(1):31-9. PubMed ID: 11233741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Two Dimensional AgNOR Evaluation in Local Advanced Rectal Cancer Treated with Chemoradiotherapy.
    Gundog M; Yildiz OG; Imamoglu N; Aslan D; Aytekin A; Soyuer I; Soyuer S
    Asian Pac J Cancer Prev; 2015; 16(18):8155-61. PubMed ID: 26745054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder cancer. A comparative study among clinicopathologic features, AgNORs, and DNA content analysis.
    Nishizawa-Takano JE; Ayabe H; Hatano K; Yamaguchi H; Tagawa Y
    Dig Dis Sci; 1996 May; 41(5):840-7. PubMed ID: 8625752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma.
    Ogura S; Abe S; Sukoh N; Kunikane H; Nakajima I; Inoue K; Kawakami Y
    Cancer; 1992 Jul; 70(1):63-8. PubMed ID: 1606548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Argyrophilic nucleolar organizer regions (AgNOR) in differentiating malignant from benign of colorectal tumors.
    Chen LT; Huang MS; Wang YL; Liu CS; Jan CM
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):615-20. PubMed ID: 7490794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma.
    Pich A; Marmont F; Chiusa L; Cappello N; Resegotti L; Navone R
    Br J Haematol; 1992 Dec; 82(4):681-8. PubMed ID: 1482655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar organizer regions in myogenic stromal tumours of the stomach.
    Sinn HP; Lehnert T; Kandetzki C; Waldherr R
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(4):317-21. PubMed ID: 2475965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between argyrophilic nucleolar organizer region (AgNOR) counts and histologic grades with respect to biologic behavior of salivary adenoid cystic carcinoma.
    Vuhahula EA; Nikai H; Ogawa I; Miyauchi M; Takata T; Ito H; Ito R
    J Oral Pathol Med; 1995 Nov; 24(10):437-42. PubMed ID: 8600278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
    Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
    Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry.
    Shimazui T; Uchiyama Y; Uchida K; Hattori K; Takahashi A; Akaza H; Koiso K
    Eur Urol; 1998; 34(5):441-7. PubMed ID: 9803008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A; Chiarle R; Chiusa L; Palestro G
    Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.